Background illustration for clinical trials search

Paid Clinical Trials Lincoln

Discover 611 paid clinical trials in Lincoln, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
FeaturedActive & Responsive

Type 2 Diabetes Studies on Blood Sugar and Weight Management for Adults Not on Insulin

for
Diabetes Mellitus, Type 2, Obesity
Location: Lincoln NE, Omaha NE, Norfolk NE, Saint Louis MO,

Sex: All

Age: 18 - 70+

Recruiting
FeaturedActive & Responsive

Pneumococcal (Pneumonia) Vaccine Studies for Healthy Adults

for
Pneumococcal Infections
Location: Lincoln NE, Omaha NE, Grand Island NE, Sioux City IA

Sex: All

Age: 18 - 70+

Recruiting

Participants receive up to $367 for time and travel

FeaturedActive & Responsive

Epstein-Barr Virus Vaccine Study to Prevent Mono in Healthy Young Adults

for
Epstein-Barr Virus Infections
Location: Lincoln NE, Omaha NE

Sex: All

Age: 18 - 30

Recruiting
FeaturedActive & Responsive

Cardiovascular Disease Studies for Adults With High Blood Pressure, High Cholesterol, AFib, or Heart Failure

for
Cardiovascular Diseases, Heart Failure, Atrial Fibrillation,
Location: Lincoln NE, Omaha NE, Norfolk NE, Englewood CO,

Sex: All

Age: 18+

Recruiting
FeaturedActive & Responsive

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

for
Metastatic Breast Cancer
Location: Omaha NE, Saint Paul MN, Zion IL, Germantown TN,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT03424005

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
FeaturedActive & Responsive

Flu and RSV Vaccine Studies for Adults 60+

for
Influenza, Human, Respiratory Syncytial Virus Infections
Location: Omaha NE, Grand Island NE, Sioux City IA,

Sex: All

Age: 60+

Recruiting
FeaturedActive & Responsive

Weight Loss Studies for Adults With a BMI of 27+, Including People Managing Type 2 Diabetes or Sleep Apnea

for
Obesity, Overweight, Diabetes Mellitus, Type 2,
Location: Omaha NE, Saint Louis MO, Englewood CO, Valparaiso IN,

Sex: All

Age: 18+

Recruiting
FeaturedActive & Responsive

COVID-19 Study for People 12+ With a Current Infection Who Are at Higher Risk of Severe Illness

for
COVID-19
Location: Omaha NE, Grand Island NE, Savannah GA, Suffolk VA,

Sex: All

Age: 12+

Recruiting

Participants receive up to $259 for time and travel

FeaturedActive & Responsive

C. diff Vaccine Studies for Adults 65+ at Higher Risk of Infection

for
Clostridium Infections
Location: Omaha NE, Grand Island NE, Sioux City IA,

Sex: All

Age: 65+

Recruiting

Participants receive up to $1,470 for time and travel

FeaturedActive & Responsive

Asthma Control Studies for Adults With Ongoing Symptoms Despite a Daily Inhaler

for
Asthma
Location: Omaha NE, Grand Island NE, Austin TX, Charleston SC,

Sex: All

Age: 18 - 70+

Recruiting
Featured

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

for
Non-Small Cell Lung Cancer, c-MET
Location: Lincoln NE, Omaha NE, Peoria IL, Springfield IL,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06568939

Phase 2, Recruiting
Featured

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Lincoln NE, Omaha NE, Rochester MN, Springdale AR,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05650632

Phase 1, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer, c-MET
Location: Lincoln NE, Saint Louis Park MN, Springdale AR,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07155187

Phase 2, Phase 3, Recruiting
Featured

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: Lincoln NE, Des Moines IA, Iowa City IA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06793215

Phase 3, Recruiting
Featured

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

for
Non-Squamous Non-Small Cell Lung Cancer, c-MET
Location: Lincoln NE, Aurora CO, Palestine TX, Austin TX,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07005102

Phase 2, Phase 3, Recruiting
Featured

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer
Location: Omaha NE, Kansas City MO, Hinsdale IL, Chicago IL,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06820463

Phase 2, Recruiting
Featured

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

for
Breast Cancer
Location: Omaha NE, Grand Island NE, Kansas City MO,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06790693

Phase 3, Recruiting
Featured

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

for
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Location: Omaha NE, Waukee IA, Swansea IL, Aurora CO,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06806033

Phase 2, Recruiting
Featured

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

for
Chronic Migraine
Location: Papillion NE, Little Rock AR, Evansville IN,
Sponsor: AbbVie

Sex: All

Age: 12 - 17

Code: NCT06810505

Phase 3, Recruiting
Featured

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

for
Migraine
Location: Papillion NE, Overland Park KS, Ames IA, Wichita KS,
Sponsor: AbbVie

Sex: All

Age: 6 - 17

Code: NCT05125302

Phase 3, Recruiting